CD40LG and Miyoshi myopathy: Compared to noncarriers, carriers of pP-7 were found to have a 6.5-fold higher risk for developing IgM MGUS and WM [146], as well as an 8-fold to 13-fold elevation of the risk for IgA/G MGUS and MM [147].